Introductory message text: (example)
Embedded link to full (30 min to one hour) presentation by medical professional on the page topic introduced above)Embedded link to 3 to 5 minute YouTube video (usually a medical professional related to the page topic)
Follow-up action plan and next step suggestions
Resources related to this topic for further and deeper information/learning related to this topic:
Lymphoma and Post-Transplant Lymphoproliferative Disorder (PTLD)
- Aull MJ, Buell JF, Trofe J, First MR, Alloway RR, Hanaway MJ, Wagoner L, Gross TG, Beebe T, Woodle ES. Experience with 274 cardiac transplant recipients with posttransplant lymphoproliferative disorder: a report from the Israel Penn International Transplant Tumor Registry. Transplantation. 2004;78(11):1676–82.
- Buell JF, Gross TG, Hanaway MJ, Trofe J, Muthiak C, First MR, Alloway RR, Woodle ES. Chemotherapy for posttransplant lymphoproliferative disorder: the Israel Penn International Transplant Tumor Registry experience. Transplant Proc. 2005;37(2):956–7.
- Buell JF, Gross TG, Hanaway MJ, Trofe J, Roy-Chaudhury P, First MR, Woodle ES. Posttransplant lymphoproliferative disorder: significance of central nervous system involvement. Transplant Proc. 2005;37(2):954–5.
- Oda D, Persson GR, Haigh WG, Sabath DE, Penn I, Aziz S: Oral Presentation of post-transplantation lymphoproliferative disorders. An unusual manifestation. Transplantation 61:435–440, 1996.
- Penn I, Hammond W, Brettschneider L, Starzl TE: Malignant lymphomas in transplantation patients. Transplantation Proceedings 1:106–112, 1969.
- Penn I, Porat G: Central nervous system lymphomas in organ allograft recipients. Transplantation 59:240–244, 1995.
- Penn I, Starzl TE: Malignant lymphomas in transplantation patients: A review of the world experience. Int J Clin Pharmacol Ther and Toxicol 3:49, 1970.
- Penn I: Conclusions of the symposium on post-transplant lymphomas. Clin Transplantation 6:275–276, 1992.
- Penn I: Host origin of lymphomas in organ transplant recipients. Transplantation 27:214, 1979.
- Penn I: Immunosuppression — a contributory factor in lymphoma formation. Clin Transplant 6:214–219, 1992.
- Penn I: Introduction to symposium (on post-transplant lymphomas). Clin Transplant 6:213, 1992.
- Penn I: Lymphomas complicating organ transplantation. Transplant Proc 15:2790–2797, 1983.
- Penn I: Malignant lymphomas in organ transplant recipients. Transplant Proc 13:736–738, 1981.
- Penn I: Re: Pseudolymphoma in renal allograft recipients. (Letter to the Editor) arch Surg 114:347, 1979.
- Penn I: Risk of lymphoma after cardiac transplantation. (Letter to the Editor) Lancet 2:1385, 1978.
- Penn I: The enigma of post-transplant lymphomas. Literature Scan: Transplantation 7(1) 1,32, 1991.
- Penn I: The role of immunosuppression in lymphoma formation. Springer. Semin Immunopathol 20:343–355, 1998.
- The role of immunosuppression in lymphomas. Recent Results Cancer Res 2002;159:55–66. Review.
- Trofe J, Buell JF, Beebe TM, Hanaway MJ, First MR, Alloway RR, Gross TG, Succop P, Woodle ES. Analysis of factors that influence survival with post-transplant lymphoproliferative disorder in renal transplant recipients: the Israel Penn International Transplant Tumor Registry experience. Am J Transplant. 2005;5(4 Pt 1):775–80.
- Trofe J, Buell JF, Woodle ES, Beebe TM, Hanaway MJ, First MR, Alloway RR, Gross TG. Recurrence risk after organ transplantation in patients with a history of Hodgkin disease or non-Hodgkin lymphoma. Transplantation. 2004;78(7):972–7.
DISCLAIMER: The content of this TRIO post-transplant cancer Web site is not influenced by sponsors. The site is designed primarily for use by transplant recipients and their supporters. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with your transplant team or a physician skilled in cancer and your organ type if you suspect you are ill.